AMANDA WHOLLY: Open Payments
NPI 1780052159 · APO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 20 payments from 8 companies in 2025. Trend: 2023 $581 · 2024 $2,429 · 2025 $914
Food & beverage: $836Education: $78
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $284 |
| ABBVIE INC. | 3 | $200 |
| pharmaand GmbH | 2 | $147 |
| GlaxoSmithKline, LLC. | 5 | $123 |
| SEAGEN INC. | 1 | $78 |
| Eisai Inc. | 1 | $35 |
| Caris MPI, Inc. | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $22 |
Products named: LYNPARZA, ELAHERE, Rubraca, JEMPERLI, Lenvima, MI CANCER SEEK, APONVIE.
Industry payments across NY — which companies pay providers there.
